Transition metal-catalysed bioorthogonal reactions are severely hindered in biomedical applications, mainly due to a lack of target specificity. Now, research shows that a trojan exosome vesicle can deliver a palladium catalyst specifically to progenitor cells for bioorthogonal catalysis, allowing localized prodrug activation.
Your institute does not have access to this article
Relevant articles
Open Access articles citing this article.
-
Catalytically potent and selective clusterzymes for modulation of neuroinflammation through single-atom substitutions
Nature Communications Open Access 07 January 2021
Access options
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$119.00
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Sletten, E. M. & Bertozzi, C. R. Angew. Chem. Int. Ed. 48, 6974–6998 (2009).
Soldevila-Barreda, J. J. & Metzler-Nolte, N. Chem. Rev. 119, 829–869 (2019).
Ji, X. et al. Chem. Soc. Rev. 48, 1077–1094 (2019).
Wang, F., Zhang, Y., Du, Z., Ren, J. & Qu, X. Nat. Commun. 9, 1209 (2018).
Sancho-Albero, M. et al. Nat. Catal. https://doi.org/10.1038/s41929-019-0333-4 (2019).
Alvarez-Erviti, L. et al. Nat. Biotechnol. 29, 341–345 (2011).
Dong, H. et al. Anal. Chem. 90, 4507–4513 (2018).
Ngo, A. H., Bose, S. & Do, L. H. Chem. Eur. J. 24, 10584–10594 (2018).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Du, Z., Qu, X. Exosomes for cell-targeted bioorthogonal catalysis. Nat Catal 2, 837–838 (2019). https://doi.org/10.1038/s41929-019-0350-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41929-019-0350-3